Human SOX17 NorthernLights™ NL557-conjugated Antibody

Catalog #: NL1924R
11 Citations Datasheet / COA / SDS

Catalog #	Availability	Size / Price	Qty
NL1924R

All SOX17 Antibodies

Product Details

Citations (11)

Reviews

Summary Preparation and Storage Reconstitution Calculator Background Product Datasheets Related Research Areas

Human SOX17 NorthernLights™ NL557-conjugated Antibody Summary

Species Reactivity

Human

Specificity

Detects human SOX17 in direct ELISAs and Western blots. In direct ELISAs, less than 1% cross-reactivity with recombinant human (rh) SOX2, rhSOX6, and rhSOX15 is observed.

Source

Polyclonal Goat IgG

Formulation

Supplied in a saline solution containing BSA and Sodium Azide.

Label

NL557 (Excitation= 557 nm, Emission= 574 nm)

Reconstitution Calculator

Preparation and Storage

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store the unopened product at 2 - 8° C. Do not use past expiration date. Protect from light.

Background: SOX17

SOX17 is a member of the SOX family of transcription factors that bind DNA via a high mobility group (HMG) domain. SOX17 is suggested to play an important role in endoderm development (1, 2). In Western blot, AF1924 detects a 60 kDa band of endogenous SOX17 which is higher than predicted molecular weight but consistent with the current literature (3).

References

Kanai-Azuma, M. et al. (2002) Development 129:2367.
Katoh, M. et al. (2002) Int. J. Mol. Med. 9:153.
Sohn, J. et al. (2006) J. Neuroscience 26:9722.

Long Name

Transcription Factor SOX17

Entrez Gene IDs

64321 (Human)

Alternate Names

FLJ22252; SOX17; SRY (sex determining region Y)-box 17; SRY-related HMG-box transcription factor SOX17; transcription factor SOX-17; VUR3

Product Datasheets

Product Datasheet

COA

SDS

Related Research Areas

Citations for Human SOX17 NorthernLights™ NL557-conjugated Antibody

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

11 Citations: Showing 1 - 10
Filter your results:

Filter by:

Derivation and characterization of the induced pluripotent stem cell line CUIMCi004-A from a patient with a novel frameshift variant in exon 18a of OCRL
Authors: G Iannello, A Patel, D Sirabella, B Corneo, VV Thaker
Stem Cell Research, 2021-12-23;59(0):102635.
Species: Human
Sample Types: Whole Tissue
Applications: IHC
Generation of the iPSC line CUIMCi003-A derived from a patient with severe early onset obesity
Authors: G Iannello, A Patel, D Sirabella, B Corneo, V Thaker
Stem Cell Research, 2021-06-21;54(0):102432.
Species: Human
Sample Types: Whole Cells
Applications: ICC
Generation of an induced pluripotent stem cell line (FRIMOi007-A) derived from an incomplete achromatopsia patient carrying a novel homozygous mutation in PDE6C gene
Authors: J Domingo-Pr, V Abad-Moral, M Riera, R Navarro, B Corcostegu, E Pomares
Stem Cell Res, 2019-09-04;40(0):101569.
Species: Human
Sample Types: Whole Cells
Applications: ICC
Generation of Best disease-derived induced pluripotent stem cell line (FRIMOi006-A) carrying a novel dominant mutation in BEST1 gene
Authors: J Domingo-Pr, M Riera, V Abad-Moral, S Ruiz-Nogal, B Corcostegu, E Pomares
Stem Cell Res, 2019-09-04;40(0):101570.
Species: Human
Sample Types: Whole Cells
Applications: ICC
Establishment of an induced pluripotent stem cell line (FRIMOi005-A) derived from a retinitis pigmentosa patient carrying a dominant mutation in RHO gene
Authors: J Domingo-Pr, M Riera, A Burés-Jels, B Corcostegu, E Pomares
Stem Cell Res, 2019-05-22;38(0):101468.
Species: Human
Sample Types: Whole Cells
Applications: ICC
Generation of two iPS cell lines (FRIMOi003-A and FRIMOi004-A) derived from Stargardt patients carrying ABCA4 compound heterozygous mutations
Authors: M Riera, A Patel, A Burés-Jels, B Corcostegu, S Chang, E Pomares, B Corneo, JR Sparrow
Stem Cell Res, 2019-02-13;36(0):101389.
Species: Human
Sample Types: Whole Cells
Applications: ICC
No evidence of involvement of E-cadherin in cell fate specification or the segregation of Epi and PrE in mouse blastocysts
Authors: K Filimonow, N Saiz, A Suwi?ska, T Wyszomirsk, JB Grabarek, E Ferretti, A Piliszek, B Plusa, M Maleszewsk
PLoS ONE, 2019-02-08;14(2):e0212109.
Species: Mouse
Sample Types: Whole Tissue
Applications: IHC-Fr
Generation of an induced pluripotent stem cell line (FRIMOi002-A) from a retinitis pigmentosa patient carrying compound heterozygous mutations in USH2A gene
Authors: M Riera, A Patel, B Corcostegu, S Chang, B Corneo, JR Sparrow, E Pomares
Stem Cell Res, 2019-01-17;35(0):101386.
Species: Human
Sample Types: Whole Cells
Applications: ICC
Establishment and characterization of an iPSC line (FRIMOi001-A) derived from a retinitis pigmentosa patient carrying PDE6A mutations
Authors: M Riera, A Patel, B Corcostegu, S Chang, JR Sparrow, E Pomares, B Corneo
Stem Cell Res, 2019-01-17;35(0):101385.
Species: Human
Sample Types: Whole Cells
Applications: ICC
Nicotinamide Ameliorates Disease Phenotypes in a Human iPSC Model of Age-Related Macular Degeneration
Authors: JS Saini, B Corneo, JD Miller, TR Kiehl, Q Wang, NC Boles, TA Blenkinsop, JH Stern, S Temple
Cell Stem Cell, 2017-01-26;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: ICC

Oct4 kinetics predict cell lineage patterning in the early mammalian embryo.
Authors: Plachta N, Bollenbach T, Pease S
Nat. Cell Biol., 2011-01-23;13(2):117-23.
Species: Mouse
Sample Types: Whole Tissue
Applications: IHC-Fr